-
The atrial fibrillation clopidogrel trial with Irbesartan for Prevention of Vascular Events (ACTIVE W) is a noninferiority trial comparing anticoagulation with warfarin to therapy with aspirin plus clopidogrel for stroke prevention in patients with atrial fibrillation.
-
12-lead ECG and lead II rhythm strip obtained from a 90-year-old woman with acute dyspnea and diaphoresis.
-
Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
-
A physicians' survey in Connecticut indicates that a patient's socioeconomic status (SES) affected their clinical management decisions.
-
A study to determine the effect of calcium supplementation on myocardial infarction, stroke, and sudden death in healthy postmenopausal women.
-
The FDA has approved, after priority review, a new non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV-1 infected adults who have failed other antiretroviral agents.
-
I've Heard of TIA, But What The Heck is a TNA?, Advancing Insulin Therapy in Type 2 Diabetes Previously Treated with Glargine Plus Oral Agents, A Relationship Between Linolenic Acid and Neuropathy in Diabetics
-
The frequency of false positive cardiac catheterization laboratory activation for suspected STEMI in community practice is relatively common with 14% of patients having no clear-cut culprit coronary artery lesions and 9.5% having no significant epicardial coronary artery disease.
-
Three criteria identify women who would benefit from empiric antibiotics for cystitis.
-
The FDA has approved another beta-adrenergic blocker.
